FindMyKOL

Michael Banov, MD

Basic profile

Medical Director of Psych Atlanta · Augusta University

ORCIDNone on fileNPI↗
✓ Itemized record
Region🇺🇸 Marietta, GA · Southeast · United StatesSpecialtyPsychiatryFocusPsychiatry
ActivityNot yet indexedFindMyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Banov is Medical Director of Psych Atlanta at Augusta University. OpenAlex indexes 26 publications with 1,587 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Updated 29 Oct 2026

Michael Banov, MD, is Medical Director of Psych Atlanta. The public record shows 26 publications with 1,587 citations (h-index 14), centered on Psychiatry. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 47 companies.

  • Top research focus: Psychiatry
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 47 companies

Generated from the cited public record · current as of 29 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)1 trialMajor Depressive Disorder1 trialAttention Deficit Disorder with Hyperactivity1 trial

Research focus

OpenAlex concept fingerprint
Psychiatry

Drugs & molecules

across trials, industry payments and publications
Vraylargeneric · CariprazineClinical trials—Industry payments212Publications—Spravatogeneric · EsketamineClinical trials—Industry payments150Publications—Auvelitygeneric · Bupropion / dextromethorphanClinical trials—Industry payments148Publications—Caplytageneric · LumateperoneClinical trials—Industry payments145Publications—Austedogeneric · DeutetrabenazineClinical trials—Industry payments87Publications—Lybalvigeneric · Olanzapine / samidorphanClinical trials—Industry payments79Publications—Rexultigeneric · BrexpiprazoleClinical trials—Industry payments78Publications—Xelstrymgeneric · DextroamphetamineClinical trials—Industry payments76Publications—Aristadageneric · Aripiprazole lauroxilClinical trials—Industry payments60Publications—Dayvigogeneric · LemborexantClinical trials—Industry payments60Publications—Uzedygeneric · RisperidoneClinical trials—Industry payments50Publications—Qelbreegeneric · ViloxazineClinical trials—Industry payments46Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments212Janssen Pharmaceuticals, IncClinical trials—Industry payments157Axsome Therapeutics, Inc.Clinical trials—Industry payments152Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments138ITI, Inc.Clinical trials—Industry payments81ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Clinical trials—Industry payments64Eisai Inc.Clinical trials—Industry payments60Neos Therapeutics, LPClinical trials—Industry payments51Otsuka America Pharmaceutical, Inc.Clinical trials—Industry payments48Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments46Vanda Pharmaceuticals Inc.Clinical trials—Industry payments41Lundbeck LLCClinical trials—Industry payments35Almatica Pharma LLCClinical trials—Industry payments34Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments34Alkermes, Inc.Clinical trials—Industry payments32Corium, LLCClinical trials—Industry payments23Neurocrine BioSciences, Inc.Clinical trials—Industry payments23Avanir Pharmaceuticals, Inc.Clinical trials—Industry payments18Noven Therapeutics, LLCClinical trials—Industry payments17Idorsia Pharmaceuticals Us IncClinical trials—Industry payments15E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments13Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments12Tris Pharma IncClinical trials—Industry payments12Bausch Health US, LLCClinical trials—Industry payments11Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments10Merck Sharp & Dohme LLCClinical trials—Industry payments8LivaNova USA, Inc.Clinical trials—Industry payments7Ironshore Pharmaceuticals Inc.Clinical trials—Industry payments6Merck Sharp & Dohme CorporationClinical trials—Industry payments4Harmony Biosciences LLCClinical trials—Industry payments3

Scholarship

indexed output and impact (OpenAlex)
26publications

Distinct works indexed by OpenAlex.

1,587citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
92companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Public positions

sourced statements on record
  • Expert faculty

    ASKP (Medical Director of Psych Atlanta listed on the faculty page)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →askp.org ↗

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

1012 Coggins Pl NE, Marietta, GA 30060

provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →Found in public academic listings, not yet independently corroborated.Collected 29 Oct 2026.View source ↗

Clinical trials

Updated 29 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 29 Oct 2026

92 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 119 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Online presence

Updated 29 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/michael-banov-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/ASKP.ORG/posts/-speaker-highlight-michael-d-banov-mdjoin-us-at-the-2026-askp3-annual-conference/1465732418887995

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
  • Instagram

    instagram.com/p/DZAJQE_jhPp

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • Other

    osmind.org/about/michael-banov-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →osmind.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 29 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”